MBM Wealth Consultants’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-59
Closed -$29K 343
2026
Q1
$29K Buy
+59
New +$32K 0.01% 183
2023
Q4
Sell
-1,555
Closed -$751K 122
2023
Q3
$751K Buy
1,555
+149
+11% +$79.4K 0.33% 49
2023
Q2
$739K Buy
1,406
+247
+21% +$133K 0.32% 48
2023
Q1
$748K Hold
1,159
0.31% 43
2022
Q4
$641K Hold
1,159
0.3% 41
2022
Q3
$606K Buy
1,159
+13
+1% +$7.28K 0.29% 40
2022
Q2
$623K Buy
1,146
+54
+5% +$29.7K 0.3% 40
2022
Q1
$645K Buy
1,092
+133
+14% +$76.4K 0.27% 50
2021
Q4
$640K Hold
959
0.27% 52
2021
Q3
$548K Buy
959
+52
+6% +$28.5K 0.25% 51
2021
Q2
$457K Buy
907
+71
+8% +$33.5K 0.21% 62
2021
Q1
$382K Buy
836
+8
+1% +$3.82K 0.19% 74
2020
Q4
$386K Sell
828
-6
-0.7% -$2.81K 0.21% 61
2020
Q3
$368K Sell
834
-19
-2% -$7.85K 0.24% 52
2020
Q2
$309K Sell
853
-507
-37% -$170K 0.22% 61
2020
Q1
$386K Buy
1,360
+25
+2% +$7.88K 0.32% 50
2019
Q4
$434K Sell
1,335
-107
-7% -$32.4K 0.32% 62
2019
Q3
$420K Buy
1,442
+41
+3% +$11.7K 0.33% 69
2019
Q2
$415K Buy
1,401
+46
+3% +$12.7K 0.34% 64
2019
Q1
$371K Buy
1,355
+1,241
+1,089% +$309K 0.33% 64
2018
Q4
$14K Buy
+114
New +$26.7K 0.01% 167

Other funds holding TMO

MBM Wealth Consultants's TMO Position: Q2 2026 in Review

MBM Wealth Consultants sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 59 shares — an estimated $29K sold.

MBM Wealth Consultants first reported a position in TMO in Q4 2018 and held it in 21 quarters. The position peaked at $751K in Q3 2023. 1,092 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MBM Wealth Consultants reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • MBM Wealth Consultants sold 59 Thermo Fisher Scientific shares in Q2 2026, an estimated $29K.
  • MBM Wealth Consultants first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 21 quarters.
  • MBM Wealth Consultants's Thermo Fisher Scientific position peaked at $751K in Q3 2023.
  • 1,092 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MBM Wealth Consultants's 13F filing for Q2 2026, filed 24 Jul 2026.